Nov 3, 2026
C4 Therapeutics to Participate in Upcoming November Investor Conferences
C4 Therapeutics, Inc. (C4T) announced that its management will participate in two upcoming investor conferences in November. These include the Guggenheim 3rd Annual Healthcare Innovation Conference on November 9, 2026, and the Jefferies Global Healthcare Conference in London on November 17, 2026. Live webcasts of both events will be available on the company's website.
Company relevance
100.00%
Company sentiment
Somewhat-Bullish
Overall sentiment
Somewhat-Bullish
Oct 29, 2026
C4 Therapeutics Unveils Expansion of Discovery Platform Capabilities Utilizing Target-Centric Approach to Accelerate the Identification of Novel Molecular Glue Degraders
C4 Therapeutics (C4T) has expanded its discovery platform by integrating a novel DNA-encoded library (DEL) into its TORPEDO® platform, enabling a target-centric approach to identify new molecular glue degraders. This new capability, which leverages C4T's cereblon-binding ligands, has already shown promising results in identifying hits against high-value targets within four months. C4T plans to utilize this enhanced platform to advance its internal pipeline focused on inflammation, neuroinflammation, and neurodegenerative diseases, and to pursue collaborations.
Company relevance
100.00%
Company sentiment
Bullish
Overall sentiment
Bullish